Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia
B Schwartzkopff,
M Mundhenke,
and
BE Strauer
Department of Cardiology, Pneumology and Angiology, Heinrich Heine University, Dusseldorf, Germany. schwartk@uni-dusseldorf.de
OBJECTIVES: The study was designed to investigate the architecture of subendocardial arterioles of patients with hypertrophic cardiomyopathy (HCM) and angina pectoris with respect to coronary vasodilator reserve. BACKGROUND: There is growing evidence that the coronary microvasculature is abnormal in HCM. Arterioles, which mainly regulate intramyocardial blood flow, are especially suspect. METHODS: Thirteen patients with HCM (50.1+/-12.6 years old, mean value +/- SD) were studied after exclusion of any relevant coronary stenoses. Subendocardial arterioles (density [n/mm2], wall area [microm2], percent lumen area [%lumen], periarteriolar collagen area [microm2]), myocyte diameter (microm) and interstitial collagen fraction (Vv%) were evaluated by means of stereologic morphometry of transvenous biopsy samples. Coronary blood flow was measured quantitatively with the inert chromatographic argon method at basal conditions and after dipyridamole (0.5 mg/kg body weight over 4 min intravenously), and coronary vasodilator reserve was calculated as the ratio of coronary resistance at basal conditions and after pharmacologic vasodilation. Data from five normotensive subjects (45.4+/-11 years old, p = NS) served as control data. RESULTS: Arteriolar density was diminished by 38% (p = 0.004) and %lumen by 13% (p = 0.009) in patients with HCM compared with control subjects. Coronary reserve was impaired in patients with HCM (2.28+/-0.6 vs. 5.34+/-1.49, p = 0.003) because of higher coronary resistance after vasodilation (0.48+/-0.14 vs. 0.22+/-0.06 mm Hg x min x 100 g/ml, p = 0.004). Coronary vasodilator reserve correlated with arteriolar density (r = +0.47, p = 0.045) and with %lumen (r = 0.65, p = 0.003). CONCLUSIONS: In HCM, the architecture of preterminal subendocardial arterioles is altered by a reduced total cross-sectional lumen area, corresponding to an impaired coronary vasodilator capacity that may predispose to myocardial ischemia.
This article has been cited by other articles:

|
 |

|
 |
 
M. F. Eleid, T. Konecny, M. Orban, P. P. Sengupta, V. K. Somers, J. M. Parish, F. Mookadam, P. A. Brady, B. L. Sullivan, B. K. Khandheria, et al.
High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy.
J. Am. Coll. Cardiol.,
November 3, 2009;
54(19):
1805 - 1809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Martinez-Lemus, M. A. Hill, and G. A. Meininger
The Plastic Nature of the Vascular Wall: Reply to Lee, Sandow, and DeMay
Physiology,
October 1, 2009;
24(5):
273 - 275.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Maron, I. Olivotto, B. J. Maron, S. K. Prasad, F. Cecchi, J. E. Udelson, and P. G. Camici
The case for myocardial ischemia in hypertrophic cardiomyopathy.
J. Am. Coll. Cardiol.,
August 25, 2009;
54(9):
866 - 875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W A Jaber, E H Yang, R A Nishimura, P Sorajja, C S Rihal, A Elesber, E Eeckhout, and A Lerman
Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
Heart,
April 1, 2009;
95(7):
564 - 569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cambronero, F. Marin, V. Roldan, D. Hernandez-Romero, M. Valdes, and G. Y.H. Lip
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis
Eur. Heart J.,
January 9, 2009;
(2009)
ehn538v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Knaapen, T. Germans, P. G. Camici, O. E. Rimoldi, F. J. ten Cate, J. M. ten Berg, P. A. Dijkmans, R. Boellaard, W. G. van Dockum, M. J. W. Gotte, et al.
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy
Am J Physiol Heart Circ Physiol,
February 1, 2008;
294(2):
H986 - H993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. I I Soliman, P. Knaapen, M. L Geleijnse, P. A Dijkmans, A. M Anwar, A. Nemes, M. Michels, W. B Vletter, A. A Lammertsma, and F. J ten Cate
Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography
Heart,
October 1, 2007;
93(10):
1204 - 1212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. McNally
Hypertrophic Cardiomyopathy: Exercise and Eat Right
Circ. Res.,
March 3, 2006;
98(4):
443 - 445.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kido, N. Hasebe, Y. Ishii, and K. Kikuchi
Tachycardia-induced myocardial ischemia and diastolic dysfunction potentiate secretion of ANP, not BNP, in hypertrophic cardiomyopathy
Am J Physiol Heart Circ Physiol,
March 1, 2006;
290(3):
H1064 - H1070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Galiuto, M Lotrionte, F Crea, A Anselmi, G G L Biondi-Zoccai, F De Giorgio, A Baldi, F Baldi, G Possati, M Gaudino, et al.
Impaired coronary and myocardial flow in severe aortic stenosis is associated with increased apoptosis: a transthoracic Doppler and myocardial contrast echocardiography study
Heart,
February 1, 2006;
92(2):
208 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sorajja, S. R. Ommen, R. A. Nishimura, B. J. Gersh, P. B. Berger, and A. J. Tajik
Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease
Circulation,
November 11, 2003;
108(19):
2342 - 2348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
J. Am. Coll. Cardiol.,
November 5, 2003;
42(9):
1687 - 1713.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Eur. Heart J.,
November 1, 2003;
24(21):
1965 - 1991.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cecchi, I. Olivotto, R. Gistri, R. Lorenzoni, G. Chiriatti, and P. G. Camici
Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
N. Engl. J. Med.,
September 11, 2003;
349(11):
1027 - 1035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.P. Dimitrow and J.S. Dubiel
Impairment of coronary microvascular flow in hypertrophic cardiomyopathy
Eur. Heart J.,
June 2, 2002;
23(12):
991 - 991.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Piech, P. E. Massart, C. Dessy, O. Feron, X. Havaux, N. Morel, J.-L. Vanoverschelde, J. Donckier, and J.-L. Balligand
Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy
Am J Physiol Heart Circ Physiol,
January 1, 2002;
282(1):
H219 - H231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Buus, M. Bottcher, F. Hermansen, M. Sander, T. T. Nielsen, and M. J. Mulvany
Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia
Circulation,
November 6, 2001;
104(19):
2305 - 2310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Mohiddin, D. Begley, J. Shih, and L. Fananapazir
Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2270 - 2278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-T. Li, C. J. Tack, L. Fananapazir, and D. S. Goldstein
Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
June 1, 2000;
35(7):
1867 - 1873.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|